Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers

M Dobrinas, J Cornuz, CB Eap - Pharmacogenetics and genomics, 2013 - journals.lww.com
Background There is a high interindividual variability in cytochrome P4501A2 (CYP1A2)
activity and in its inducibility by smoking, only poorly explained by known CYP1A2 …

Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers

M Dobrinas, J Cornuz, CB Eap - Pharmacogenetics and …, 2013 - pubmed.ncbi.nlm.nih.gov
Background There is a high interindividual variability in cytochrome P4501A2 (CYP1A2)
activity and in its inducibility by smoking, only poorly explained by known CYP1A2 …

Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.

M Dobrinas, J Cornuz, CB Eap - Pharmacogenetics and genomics, 2013 - folia.unifr.ch
METHODS CYP1A2 activity was determined by the paraxanthine/caffeine ratio in 184
smokers and in 113 of them who were abstinent for 4 weeks. Participants were genotyped …

Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers.

M Dobrinas, J Cornuz, CB Eap - Pharmacogenetics and Genomics, 2013 - europepmc.org
Background There is a high interindividual variability in cytochrome P4501A2 (CYP1A2)
activity and in its inducibility by smoking, only poorly explained by known CYP1A2 …

[引用][C] Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers

M Dobrinas, J Cornuz, CB Eap - Pharmacogenetics and Genomics, 2013 - cir.nii.ac.jp
Pharmacogenetics of CYP1A2 activity and inducibility in smokers and exsmokers | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …